Brief
Inventia Rastrum’s unique, high-speed 3D printer/bioink system combines specific liquids, cancer cells and human cells in different combinations utilizing a printing technique to form 3D gel spheroids which mimic human tissue.
Rastrum’s ability to accurately print different spheroids consistently, at high speed, enables researchers to run many more experiments to test the ability of certain drug combinations to kill cancer.
Investment
October 2018. Seed. Lead Partner: Mike Nicholls
Co-Investors
Blackbird